MedPath

Robotic Rehabilitation and Brain Stimulation for Children With Hemiparetic Cerebral Palsy

Phase 2
Conditions
Hemiplegic Cerebral Palsy
Perinatal Stroke
Registration Number
NCT04233710
Lead Sponsor
University of Calgary
Brief Summary

This study evaluates the use of robotic rehabilitation with and without transcranial direct current stimulation (tDCS) to improve motor performance in children with hemiparetic cerebral palsy. Half of the participants will receive robotic rehabilitation and half will receive robotic rehabilitation with tDCS. We hypothesize that tDCS may augment the robotic therapy and show greater improvements than robotic therapy alone.

Detailed Description

The defining feature of hemiparetic cerebral palsy is motor impairments primarily on one side of the body. Robotic rehabilitation and non-invasive brain stimulation are both emerging technologies that may be beneficial in improving motor performance in individuals with hemiparetic cerebral palsy. Robotic rehabilitation can allow for hundreds of arm movements in the span of an hour, a level of concentrated repetitions that is not possible in traditional rehabilitation. Additionally, robotics can target specific deficits, such as coordinating both arms together, improving accuracy of reaching movements, or improving proprioception, while simultaneously giving the therapist and patient quantitative feedback on performance. Non-invasive brain stimulation using transcranial direct current stimulation (tDCS) can safely modulate activity in regions of the brain and has emerged as a tool to enhance motor learning in typically developing children and augment therapy in children with hemiparetic cerebral palsy.

Children with hemiparetic cerebral palsy will be randomized to receive robotic rehabilitation with tDCS or robotic rehabilitation with sham-tDCS. Participants and the assessors will be blinded to the treatment. All children will complete 10 sessions within 3 weeks of 1.5 hours of robotic rehabilitation. The Kinarm Exoskeleton Robot will be used and children will play games with their affected arm or both arms to target different aspects of sensorimotor control. Children will simultaneously receive real or sham tDCS for the first 20 minutes of the session. tDCS will consist of 1 mA current with the cathode applied over the contralesional M1 area. All children will be assessed before and after the 10 session intervention period using robotic and clinical measures of motor and sensory performance, and at a 3 month follow up.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  • confirmed diagnosis of hemiparetic cerebral palsy due to unilateral perinatal stroke
  • age 6-18 years
  • Manual Ability Classification System (MACS) Level I-III
  • Modified Ashworth Score in shoulder and elbow <=3;
  • Visual acuity (corrected) better than 20/50 in both eyes
  • able to follow instructions and comply with protocol;
  • able to give consent/assent;
  • able to commit to all assessment and intervention sessions.
Exclusion Criteria
  • significant contractures in the upper extremity;
  • other neurological conditions or active medical disease;
  • unstable epilepsy;
  • contraindications to tDCS;
  • botulinum toxin A injections in the upper extremity in the past 6 months;
  • upper extremity surgical intervention in past 6 months;
  • involvement in another interventional study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Reaching Accuracychange between pre-assessment (within 1 week of starting intervention) and post-assessment (within 1 week of completing intervention)

Change in reaching accuracy as measured by initial direction error on robotic visually guided reaching task.

Secondary Outcome Measures
NameTimeMethod
Standardized robotic measures of motor and sensory performancechange between pre-assessment (within 1 week of starting intervention) and post-assessment (within 1 week of completing intervention)

Robotic measures of spatiotemporal reaching (path length ratio, reaction time, movement speed, number of speed maximums), proprioception (variability in position matching) and bilateral object hitting task (number of balls hit with each hand). Each measure will be assessed as change from pre-assessment to immediate post-assessment

Assisting Hand Assessmentchange between pre-assessment (within 1 week of starting intervention) and post-assessment (within 1 week of completing intervention)

Performance on clinical assessment that determines how effectively the affected limb is used on tasks typically requiring both arms.

Box and Block Assessmentchange between pre-assessment (within 1 week of starting intervention) and post-assessment (within 1 week of completing intervention)

Measure of ability to reach, grasp and release that measures how many 1" cubes a child can move from one side of a box to another in 1 minute.

Purdue Pegboardchange between pre-assessment (within 1 week of starting intervention) and post-assessment (within 1 week of completing intervention)

Measure of manual dexterity measured by how many small pegs a child can place in a pegboard in 30 seconds.

Trial Locations

Locations (1)

Alberta Children's Hospital

🇨🇦

Calgary, Alberta, Canada

Alberta Children's Hospital
🇨🇦Calgary, Alberta, Canada
Rachel L Hawe, DPT, PhD
Contact
403-944-1094
rachel.hawe@ucalgary.ca

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.